文献速递临床微生物质量管理与危急值

中国多中心研究:须癣毛癣菌与指间毛癣菌对八种抗真菌药的体外敏感性及暂定流行病学折点

In vitro susceptibility and provisional epidemiological cutoff values for eight antifungal agents against Trichophyton mentagrophytes and Trichophyton interdigitale: a multicenter study from China.
PubMed 文献 · J Clin Microbiol · 2026-08-21

该多中心研究收集中国六家三级医院2019至2024年305株须癣毛癣菌和指间毛癣菌,用CLSI M38微量稀释法测八种抗真菌药敏感性,按CLSI M57推导暂定流行病学折点。两种菌MIC分布不同,除指间毛癣菌对灰黄霉素外,超折点菌株少见。

要点

  • 须癣毛癣菌对氟康唑MIC非单峰,未定ECV;其余七种药ECV为0.016至1 µg/mL。
  • 指间毛癣菌对氟康唑、伊曲康唑和泊沙康唑因分布异常或低MIC肩不稳定未定ECV。
  • 多数药物-菌种组合超暂定ECV菌株比例≤2.5%,但指间毛癣菌对灰黄霉素达20.5%。

核心结论

  • 两种毛癣菌的MIC分布不同,支持按菌种水平解读药敏数据并持续监测。
  • 该多中心CLSI数据为中国皮肤癣菌药敏判读提供了当代基线。

研究设计与样本

  • 多中心研究,收集中国六家三级医院2019至2024年的305株须癣毛癣菌和指间毛癣菌。
  • 采用CLSI M38肉汤微量稀释法并在标准化质控下进行药敏试验,按CLSI M57指南推导暂定ECV。

主要发现

  • 须癣毛癣菌对氟康唑MIC分布非单峰,未分配暂定ECV。
  • 须癣毛癣菌对其余七种药的暂定ECV:环吡酮胺和灰黄霉素1 µg/mL,伊曲康唑0.5 µg/mL,伏立康唑0.06 µg/mL,泊沙康唑和阿莫罗芬0.25 µg/mL,特比萘芬0.016 µg/mL。
  • 指间毛癣菌对氟康唑呈复杂非单峰分布,伊曲康唑和泊沙康唑低MIC肩不稳定,均未估计ECV。
  • 指间毛癣菌对其余五种药的暂定ECV:环吡酮胺1 µg/mL,灰黄霉素0.25 µg/mL,伏立康唑和阿莫罗芬0.12 µg/mL,特比萘芬0.016 µg/mL。
  • 多数药物-菌种组合超暂定ECV菌株比例≤2.5%,但指间毛癣菌对灰黄霉素为20.5%。

关键数值与推荐

  • 须癣毛癣菌暂定ECV:环吡酮胺1 µg/mL、灰黄霉素1 µg/mL、伊曲康唑0.5 µg/mL、伏立康唑0.06 µg/mL、泊沙康唑0.25 µg/mL、阿莫罗芬0.25 µg/mL、特比萘芬0.016 µg/mL。
  • 指间毛癣菌暂定ECV:环吡酮胺1 µg/mL、灰黄霉素0.25 µg/mL、伏立康唑0.12 µg/mL、阿莫罗芬0.12 µg/mL、特比萘芬0.016 µg/mL。
  • 须癣毛癣菌对氟康唑未分配暂定ECV;指间毛癣菌对氟康唑、伊曲康唑和泊沙康唑未估计ECV。

临床怎么用

  • 实验室可按菌种水平参照上述暂定ECV识别敏感性降低的分离株。
  • 对指间毛癣菌-灰黄霉素组合应留意超ECV菌株比例较高(20.5%)。

局限性

  • 部分菌种-药物组合因MIC分布非单峰或低MIC肩不稳定未能推导暂定ECV。
  • 暂定ECV非临床折点,其临床意义仍需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Dermatophytosis is a highly prevalent superficial fungal infection, yet antifungal susceptibility testing results remain difficult to interpret because clinical breakpoints are unavailable, and epidemiological cutoff values (ECVs) are still limited for most dermatophyte-drug combinations. We conducted a multicenter study of 305 Trichophyton mentagrophytes and Trichophyton interdigitale isolates collected between 2019 and 2024 at six tertiary hospitals across geographically diverse regions of China. Antifungal susceptibility testing was performed using the CLSI M38 broth microdilution method under standardized quality control, and provisional ECVs were derived following CLSI M57 guidance. For T. mentagrophytes, fluconazole showed a non-unimodal MIC distribution and was not assigned a provisional ECV. The remaining seven agents yielded ECVs of 1 µg/mL for ciclopirox olamine and griseofulvin, 0.5 µg/mL for itraconazole, 0.06 µg/mL for voriconazole, 0.25 µg/mL for posaconazole and amorolfine, and 0.016 µg/mL for terbinafine. For T. interdigitale, fluconazole showed a complex non-unimodal distribution, whereas itraconazole and posaconazole showed unstable low-MIC shoulders precluding ECV estimation. The remaining five agents yielded ECVs of 1 µg/mL for ciclopirox olamine, 0.25 µg/mL for griseofulvin, 0.12 µg/mL for voriconazole and amorolfine, and 0.016 µg/mL for terbinafine. Isolates above the provisional ECVs were uncommon for most combinations (≤2.5%), except for griseofulvin against T. interdigitale (20.5%). Overall, the two species showed distinct MIC distribution profiles, underscoring the value of species-level analysis and continued surveillance. These multicenter CLSI-based data and provisional ECVs provide a contemporary baseline for species-specific interpretation of dermatophyte susceptibility data in China. IMPORTANCE: Reliable interpretation of dermatophyte antifungal susceptibility testing remains limited because clinical breakpoints and epidemiological cutoff values (ECVs) are unavailable for most dermatophyte-drug combinations. This is particularly important for the Trichophyton mentagrophytes/Trichophyton interdigitale species complex, which is increasingly implicated in refractory dermatophytosis and may display species-specific susceptibility patterns. In this multicenter study, we established provisional epidemiological cutoff values for most tested species-agent combinations and showed that these two closely related species differ in MIC distribution profiles and in the detection of non-wild-type isolates. These data provide practical laboratory thresholds for recognizing isolates with reduced susceptibility, highlight the limitations of complex-level interpretation, establish a contemporary baseline for dermatophyte susceptibility surveillance in China, and may help support laboratory-informed antifungal decision-making.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Zheng H, Xie W, Song Y, et al. In vitro susceptibility and provisional epidemiological cutoff values for eight antifungal agents against Trichophyton mentagrophytes and Trichophyton interdigitale: a multicenter study from China. J Clin Microbiol. 2026. PMID: 42626940. doi:10.1128/jcm.00567-26

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。